Recent research has highlighted the potential of NMN, a supplement that boosts NAD+ levels, to reverse certain aging effects. Dr. David Sinclair fr...
The Antifibrotic Drug Development Summit is set to take place this November, showcasing significant advancements in the field of antifibrosis. The ...
Recent research published in the journal PNAS has revealed that migratory flamingoes, which travel annually from the Camargue region of France to I...
Harvard Medical School researchers have identified lithium deficiency in the brain as a potential early trigger for Alzheimer's disease. Published ...
Researchers have identified patterns in gene families that correlate with longevity in mammals, according to a study led by Dr. Benjamin Padilla-Mo...
Devonian Health Group Inc., a clinical-stage pharmaceutical company, has announced significant advancements in the development of Thykamine, a drug...
Recent research has focused on the treatment of asciminib-resistant chronic myeloid leukemia (CML) using a combination of venetoclax and ponatinib....
Devonian Health Group Inc., a clinical stage pharmaceutical company, has provided a corporate update regarding its ongoing projects and financial a...
Recent research has demonstrated that the HDAC inhibitor romidepsin can make liver cancer cells more susceptible to RTK targeting, enhancing their ...
Harvard Medical School researchers have discovered that a deficiency of lithium in the brain may be a key factor in the development of Alzheimer's ...